In the article on electron-beam tomography in the May 27 issue of Circulation, Kondos et al 1 report on calcium scores and events in a self-referred population who presumably paid out of pocket for their scans. Unfortunately, despite the large number of patients in this study, the data were not gathered in a manner that helps us to better understand the role of coronary calcification in risk prediction for cardiovascular events.
Response
We appreciate the comments from Dr Redberg regarding our recently published article 1 and agree that coronary artery calcium (CAC) may be more properly characterized as a risk marker rather than a risk factor. CAC as measured by electron-beam tomography (EBT) is one of a few noninvasive markers for coronary atherosclerosis. [2] [3] [4] However, Although there is no direct treatment for CAC, it has been reported that the extent to which the volume of EBT CAC decreases, stabilizes, or increases is directly related to treatment with 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase inhibitors and the resulting serum LDL cholesterol levels. 5 Thus, CAC may be subject to modification as the result of interventions on risk factors.
In our study, all participants were initially asymptomatic, and all reported events were verified. To ensure that revascularization procedures were not triggered solely by positive EBT results, medical record documentation of unstable angina or a positive stress test was a required component of the end point definition, and revascularization procedures (coronary artery bypass grafting or catheter-based interventions) not meeting the requirements were excluded from the analysis. Our main finding that presence and degree of CAC was a significant predictor of subsequent coronary events-particularly of soft events-indicates the soundness of utilizing EBT as a screening tool for the identification of individuals with subclinical disease who can benefit from additional testing and interventions. Further, although our data do not permit the computation of Framingham risk scores, our multivariate results suggest that the CAC score provides incremental prognostic information beyond that provided by assessment of established coronary risk factors.
Given the weight placed on age in the Framingham equation and the high correlation of age with CAC score, it is perhaps not surprising that a study 6 conducted in high-coronary-risk subjects whose average age was 66 years reported no incremental value of CAC determination over the Framingham risk score. Indeed, the substitution of CAC score for age in risk assessment equations has been proposed. 7 In our study, average age was Ϸ51 years, and participants were not at high risk for CHD.
We do not suggest that established methods of coronary risk estimation be replaced by EBT screening for CAC, but we do advocate continued research to determine what role EBT screening should play in assessing CHD risk and whether or not, as our findings suggest, measurement of CAC can be viewed as a tool providing additional prognostic information beyond assessment of risk using traditional CHD risk factors.
